Publication | Open Access
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up
278
Citations
38
References
2018
Year
ClinicalTrials.gov identifier: NCT01633970.
| Year | Citations | |
|---|---|---|
Page 1
Page 1